Company: ARWR
Filing Date: 2025-02-10
Form Type: 10-Q
Source: 0001628280-25-004634
Chunk: 68

Company: ARROWHEAD PHARMACEUTICALS, INC.
Filing Date: 2025-02-10
Form: 10-Q
Item: Part I, Item 8
Chunk 68
---
 restricted and unrestricted stock, stock units (including restricted stock units), performance awards, cash awards, and other awards convertible into or otherwise based on shares of the Company’s common stock. Awards under the Inducement Plan may only be granted to new employees of the Company in accordance with the provisions of Rule 5635(c)(4) of the Nasdaq Listing Rules. As of December 31, 2024, the total number of shares remaining available for issuance was 453,601 shares, and 428,800 shares have been granted under the Inducement Plan.In addition, prior to adoption of the Inducement Plan, the Company previously granted stand-alone inducement awards in the form of stock options and restricted stock units outside of the Company’s equity plans to new employees under Rule 5635(c)(4) of the Nasdaq Listing Rules. As of December 31, 2024, there were 602,939 and 183,750 shares underlying outstanding stand-alone inducement options and restricted stock units, respectively.The following table presents a summary of awards outstanding attributable to Arrowhead Pharmaceuticals, Inc.:As of December 31, 20242013 Plan2021 PlanInducement AwardsTotalGranted and outstanding awards:Options1,248,038 32,151 602,939 1,883,128 Restricted stock units1,607,885 2,943,382 512,507 5,063,774 Total2,855,923 2,975,533 1,115,446 6,946,902 The following table summarizes stock-based compensation expenses included in operating expenses:Three Months Ended December 31,20242023(in thousands)Research and development$6,846 $7,823 General and administrative7,329 9,862 Total$14,175 $17,685 Stock Option AwardsThe following table presents a summary of the stock option activity for the three months ended December 31, 2024:SharesWeighted-AverageExercisePricePer ShareWeighted-AverageRemainingContractualTerm (Years)AggregateIntrinsicValueOutstanding at September 30, 20241,978,516$23.39 Granted—— Cancelled or expired(25,882)40.20 Exercised(69,506)9.06 Outstanding at December 31, 20241,883,128$23.69 3.3$12,408,737 Exercisable